Health
Persistent immune thrombocytopaenic purpura associated with SARS‐CoV‐2 infection – Wiley
Click on the article title to read more.
We describe evolution of persistent immune thrombocytopaenic purpura (ITP) from acute ITP in a young woman with clinically otherwise inapparent severe acute respiratory syndrome coronavirus 2 (SARSCoV2) infection (COVID19); her development of ITP was matter for an earlier report.[1] ITP is an acquired disease in which thrombocytopaenia results from autoantibodies against platelet antigens. Approximately 10% of patients with acute ITP develop persistent (lasting 312 months) or chronic (>12 months)…
-
Business18 hours agoWarning! These ASX 200 shares were just downgraded
-
Business11 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Business16 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
Noosa News7 hours agoTwo-time Archibald Prize-winning painter William Robinson has died, aged 89